OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 499-510
Open Access | Times Cited: 24
Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 499-510
Open Access | Times Cited: 24
Showing 24 citing articles:
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Xiangyuan Chu, Yu Tian, Chao Lv
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Xiangyuan Chu, Yu Tian, Chao Lv
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58
Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells
Zhi-Liang Jing, Guang‐long Liu, Na Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Zhi-Liang Jing, Guang‐long Liu, Na Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Epigenetic regulation of cancer-associated fibroblast heterogeneity
Rachel J. Kehrberg, Namita Bhyravbhatla, Surinder K. Batra, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188901-188901
Open Access | Times Cited: 19
Rachel J. Kehrberg, Namita Bhyravbhatla, Surinder K. Batra, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188901-188901
Open Access | Times Cited: 19
Comprehensive Integrated Analysis Reveals the Spatiotemporal Microevolution of Cancer Cells in Patients with Bone-Metastatic Prostate Cancer
Yinghua Feng, Xiuli Zhang, Guangpeng Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 909-909
Open Access
Yinghua Feng, Xiuli Zhang, Guangpeng Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 909-909
Open Access
Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis
Rakesh Bhatia, Jawed A. Siddiqui, Koelina Ganguly, et al.
Oncogene (2023) Vol. 42, Iss. 10, pp. 759-770
Open Access | Times Cited: 11
Rakesh Bhatia, Jawed A. Siddiqui, Koelina Ganguly, et al.
Oncogene (2023) Vol. 42, Iss. 10, pp. 759-770
Open Access | Times Cited: 11
Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy
Daniel Hughes, Alice C. Evans, Simei Go, et al.
Science Advances (2024) Vol. 10, Iss. 27
Open Access | Times Cited: 4
Daniel Hughes, Alice C. Evans, Simei Go, et al.
Science Advances (2024) Vol. 10, Iss. 27
Open Access | Times Cited: 4
Leptin decreases Th17/Treg ratio to facilitate neuroblastoma via inhibiting long-chain fatty acid catabolism in tumor cells
Meng Li, Di Li, Haiyun Wang, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Meng Li, Di Li, Haiyun Wang, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Insights on metabolic connections and interplay between cancer and diabetes: role of multi-target drugs
Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases
Yuxiang Liu, Nianshuang Li, Yin Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4027-4027
Open Access | Times Cited: 10
Yuxiang Liu, Nianshuang Li, Yin Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4027-4027
Open Access | Times Cited: 10
Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis
Hongkun Cai, Jingyuan Zhao, Qiyue Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167183-167183
Closed Access | Times Cited: 3
Hongkun Cai, Jingyuan Zhao, Qiyue Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167183-167183
Closed Access | Times Cited: 3
Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine): Promising biomedical materials for building stimuli-responsive nanocarriers
Lingcong Zeng, Dandan Kang, Linglin Zhu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 810-828
Closed Access | Times Cited: 3
Lingcong Zeng, Dandan Kang, Linglin Zhu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 810-828
Closed Access | Times Cited: 3
Three‐in‐One Oncolytic Adenovirus System Initiates a Synergetic Photodynamic Immunotherapy in Immune‐Suppressive Cholangiocarcinoma
Jialun Wang, Yun Zhu, Yu Chen, et al.
Small (2023) Vol. 19, Iss. 34
Closed Access | Times Cited: 8
Jialun Wang, Yun Zhu, Yu Chen, et al.
Small (2023) Vol. 19, Iss. 34
Closed Access | Times Cited: 8
Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma
Lihong He, Xiaozhen Zhang, Fukang Shi, et al.
Cell Reports Medicine (2024), pp. 101731-101731
Open Access | Times Cited: 2
Lihong He, Xiaozhen Zhang, Fukang Shi, et al.
Cell Reports Medicine (2024), pp. 101731-101731
Open Access | Times Cited: 2
Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model
Hyun‐Ah Kim, Hyun‐Soo Kim, Min‐Kyung Nam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Hyun‐Ah Kim, Hyun‐Soo Kim, Min‐Kyung Nam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
GLI1 interaction with p300 modulates SDF1 expression in cancer-associated fibroblasts to promote pancreatic cancer cells migration
Renzo E. Vera, María Julia Lamberti, Luciana L. Almada, et al.
Biochemical Journal (2023) Vol. 480, Iss. 3, pp. 225-241
Open Access | Times Cited: 5
Renzo E. Vera, María Julia Lamberti, Luciana L. Almada, et al.
Biochemical Journal (2023) Vol. 480, Iss. 3, pp. 225-241
Open Access | Times Cited: 5
Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment
Giulio Giustarini, Germaine Teng, Andrea Pavesi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Giulio Giustarini, Germaine Teng, Andrea Pavesi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Human Genetics (2024)
Open Access | Times Cited: 1
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Human Genetics (2024)
Open Access | Times Cited: 1
Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma
Dae Ui Lee, Beom Seok Han, Kyung Hee Jung, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 281-290
Open Access | Times Cited: 1
Dae Ui Lee, Beom Seok Han, Kyung Hee Jung, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 281-290
Open Access | Times Cited: 1
Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer
Xingyi Lin, Ying Tan, Lele Pan, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 3, pp. 237-251
Closed Access | Times Cited: 2
Xingyi Lin, Ying Tan, Lele Pan, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 3, pp. 237-251
Closed Access | Times Cited: 2
Targeting the Cascade Amplification of Macrophage Colony-stimulating Factor to Alleviate the Immunosuppressive Effects Following Radiotherapy
Zhiyun Liao, Yi‐Jun Wang, Yuxin Yang, et al.
Research (2024) Vol. 7
Open Access
Zhiyun Liao, Yi‐Jun Wang, Yuxin Yang, et al.
Research (2024) Vol. 7
Open Access
The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer
Yingying Liu, Ke Zhang, Xiaodi Cai, et al.
Oncology Letters (2024) Vol. 29, Iss. 2
Open Access
Yingying Liu, Ke Zhang, Xiaodi Cai, et al.
Oncology Letters (2024) Vol. 29, Iss. 2
Open Access
Editorial: Role of chemokines in tumor heterogeneity
Jawed A. Siddiqui, Mohd W. Nasser
Seminars in Cancer Biology (2023) Vol. 92, pp. 128-129
Closed Access
Jawed A. Siddiqui, Mohd W. Nasser
Seminars in Cancer Biology (2023) Vol. 92, pp. 128-129
Closed Access
The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Research Square (Research Square) (2023)
Open Access
CDCA7: A Comprehensive Pan-Cancer Analysis Reveals its Prognostic Significance, Immune Correlations, and Therapeutic Potential
Wenli Ding, Xuebing Cheng, Hui Li, et al.
Research Square (Research Square) (2023)
Open Access
Wenli Ding, Xuebing Cheng, Hui Li, et al.
Research Square (Research Square) (2023)
Open Access
